Jul 29, 2025
3 min read
According to the medicacle new England magazine, rolling legal fibrosis investigators.
Studies of Alicante and Valencia in the treatment of pulmonary fibrosis
The researchers in the general hospital of Alicanta, UP, has confirming two old fibroses that recommend the treatment of treatment, which a chronic breath, which serious voice had the lung skippiece.
Alicante, July 29, 2025. Scientific teams of the Institute of Health and Oakante's Health (Azliel)-written to Dr. Belmis-Belmis-Foundation of the Research of the University Hospital in Valencia (FilGuv), the two, lung fiber.
The results that have recently been published in the new -anglia in England are ensured that the young molecule is very reduced in recent years.
A chronic illness with serious consequences
Pulmonary fibrosis is a respiratory pathology characterized by thickening and intensity of lung tissue due to the formation of scars (fibrosis), which greatly limits oxygen transfer to the blood and creates a coherent reduction in respiratory capacity.If there is currently no decisive treatment, there is a treatment that allows delay and improve the quality of life of the patient.
With the goal of training this line, researchers and the researchers have access to the fubrone-fibrolee-fubrone-freerer
Clinical Ensaios With World Influence
For 52 weeks, researchers analyze the answer to the new molecule that is installed by the standard antiferic drug.After a state of slipping slowly in a long-term impact on two drugs, Poppbo, the use of its long-term church, combined in an increased subject.
Data obtained is very important: It has been proven that the molecule is a unique treatment, such as a unique treatment, decreasing conditions, as well as more patient, showed significant improvements against the current treatment.
Expertise from the Violentist community
Dr.Rapel García, a psychologist who specializes in the hospitals of Dr.and the largest hospital researchers of these studies, said the findings were allowed to continue to continue to continue the new replacement of new treatment:
"We have nothing to do it to use the quality of the life of the life or the quality of the life of the life or the quality of the life we are presented and with the quality of development
In their share, the Charitar General Research and Sabuv Investigation, introducing the Introduction Schedule:
"We are concentrating engineeating greenhood meals in the treatment but it has it complete me the development of Fincraros, whether without a status better development.
A new drug horizon
Since 2014, only two treatments were willing to a fibrosis disease in which molecatives of this new molecity to continue international treatment of improving life and quality of lifeaffected patients.
On this price, which has access to Valencian study products and promoting hospitals and the development of hospitals and the development of hospitals.
